State-of-the-art review: stress T1 mapping—technical considerations, pitfalls and emerging clinical applications
- 851 Downloads
In vivo mapping of the myocardial T1 relaxation time has recently attained wide clinical validation of its potential utility. In this review, we address the basic principles of the T1 mapping techniques, with particular attention to the emerging application of vasodilatory stress agents to interrogate the myocardial microvascular compartment, and differences between commonly used T1 mapping methods when applied in clinical practice.
KeywordsCardiovascular magnetic resonance Vascular reactivity Stress Tissue characterization T1 mapping
Introduction: what is T1 mapping?
T1 relaxation time, spin-lattice relaxation time, or simply T1, is the fundamental magnetic resonance property that describes the exponential recovery of the longitudinal component of magnetization (Mz) back towards its thermal equilibrium. In vivo, the recovery of Mz is complex, but characterizing the underlying processes with a single T1 value has shown promise as a biomarker . The measured T1 is determined by intrinsic tissue properties, and the extrinsic environment, including surrounding structure and milieu, as well as software and hardware used to measure T1. Modern sequences allow direct generation of spatially resolved T1 relaxation maps. T1 mapping of tissues allows immediate assessment of their T1 values on a voxel-by-voxel basis as a method of direct quantitative tissue characterization. In general, each tissue type is expected to have a normal range of T1 values, deviation from which may indicate disease or a change in physiology.
T1 mapping sequences
Myocardial T1 values measured in vivo depend on the chosen method, and are influenced by technical factors, such as magnetic field strength and pulse sequence design, and physiologic factors, including heart rate, temperature, age, gender, and disease . The general design of T1 mapping sequences includes delivery of a pre-pulse and acquisition of multiple T1-weighted images to allow fitting of these signals to an exponential recovery curve. Common T1 mapping sequences used for cardiac T1 mapping are inversion recovery techniques [2, 3, 4, 5], saturation recovery techniques , and mixed hybrid approaches .
Short breath-holds: it significantly shortened the breath-hold time to 9 heartbeats (usually around 10 s) per T1 map, rendering imaging time easier for sicker patients to cope with .
Heart rate independence: it eliminated heart rate dependency characteristic of other MOLLI-based techniques and variants, and is able to cope with tachyarrhythmias, such as rapid atrial fibrillation, frequent ectopic beats, and sinus tachycardia; this is particularly relevant for performing mapping during dynamic heart rate changes, such as for stress applications [3, 14, 27, 28, 29].
Flexibility: ShMOLLI is a one-for-all technique for a wide range of T1. In particular, it estimates long T1s without the progressive heart rate-dependent underestimation typical of MOLLI . This is relevant for tissues such as blood (in the range of up to 2000 ms) and fluids such as in pericardial effusions, cysts, and cerebrospinal fluid (in the range of 3000–4000 ms). This feature is also important for assessing edematous tissues, and extracellular volume (ECV) where blood T1 is required. Other novel applications include characterization of masses (e.g. differentiating cysts from solid tumors) [30, 31], and splenic T1 to determine stress adequacy, which requires a T1 mapping sequence that can handle both long T1 values and in dynamic stress conditions [10, 11, 29, 32].
- 4.Practicality: ShMOLLI is able to simultaneously estimate short and long T1 pixels in the same image without requiring separate sequence sampling schemes for pre- and post-contrast T1 applications ; this makes it highly convenient in the practical workflow for ECV applications. It also allows post-contrast characterization of masses to determine gadolinium uptake, without misclassifying a cyst as a mass that appears to take up gadolinium contrast agents, which may, for example, suggest a vascular tumour on post-contrast T1 maps (Fig. 2).
There are other short MOLLI variants that have been developed also aimed at shortening imaging times [4, 33]. Currently, MOLLI-based sequences are the most commonly used and validated, although saturation-recovery single-shot acquisition (SASHA, SmarT1Map) sequences have attracted much attention due to acceptable short imaging times, nominal lack of heart rate dependency and excellent accuracy in estimating myocardial T1 times shown in simulation and in phantoms [34, 35]. Hybrid approaches that combine saturation and inversion pulses are also available as emerging techniques for cardiac applications .
What do T1 measurements bring to clinical practice?
Myocardial T1 mapping methods can be used for native (or pre-contrast) T1 mapping, post-contrast T1 mapping, and ECV mapping (detailed review may be accessed elsewhere ). Briefly, native (pre-contrast) T1 reflects a composite signal from both the intracellular (predominantly myocytes) and extracellular spaces (which includes the interstitial and intravascular compartments). T1 predominantly detects free water, and increased free water content in tissue, such as edema or water collecting in expanded interstitial spaces. T1 does not directly detect collagen fibers, but predominantly the accumulation of water around fibrotic tissue which typically prolongs native T1 relaxation times and is responsible for the strong indirect links to areas of fibrosis reported in the literature. Processes that are known to lower T1 times include significant iron and fat content [26, 37, 38], as well as contrast agents, particularly gadolinium. Isolated, single time-point post-contrast T1 mapping is currently not preferred to estimating the ECV, due to strong dependencies on the timing and dose of contrast administered, and other confounding factors . Instead, ECV may be quantified non-invasively using pre- and post-contrast T1 maps to obtain pre- and post-contrast myocardial and blood T1 values, adjusting for the hematocrit.
Principle of gadolinium-free T1 mapping to assess the coronary vascular compartment
Stress and rest T1 mapping in coronary artery disease (CAD)
Stress T1 mapping has obvious potential applications in patients with CAD and ischemic heart disease [28, 47]. Liu et al.  demonstrated that, in normal myocardium, the resting T1 is normal, with a 6% rise during vasodilatory stress. In chronic infarcted myocardium, the resting T1 is typically significantly elevated compared to normal myocardium, with no change in T1 during stress (Fig. 4). In ischaemic myocardium subtended by a significant coronary stenosis, there is compensatory downstream coronary vasodilation even at rest; this is detectable as mildly elevated resting myocardial T1 values, but do not show further coronary vasodilatory response during stress, and, thus, no change in stress myocardial T1. Adenosine stress and rest T1 mapping may be used to distinguish normal, infarcted, and ischaemic myocardium, without the need for GCBA, due to their distinctive rest and stress T1 profiles  (Fig. 4).
Stress and rest T1 mapping in patients without obstructive CAD
Splenic T1 mapping: a novel surrogate marker for adequate adenosine stress
Pitfalls of stress T1 mapping
The impact of the chosen T1 mapping technique on rest and stress T1
It is widely recognized that T1 mapping techniques, even within a method family like MOLLI-based sequences, have different properties and diverging norms [1, 55]. The impact of this issue is particularly apparent for stress T1 applications, as illustrated by two recent studies that used different MOLLI techniques to perform adenosine stress T1 mapping: Liu et al.  performed stress T1 mapping using ShMOLLI to study normal volunteers compared to patients with CAD, while Kuijpers et al. used MOLLI 5(3)3 stress T1 mapping to study patients who had normal findings on conventional CMR (served as controls) compared to CAD patients. Liu et al. observed a normal stress T1 response of 6.2 ± 0.5% at 1.5 T and 6.3 ± 1.1% at 3 T , while Kuijpers et al. obtained a lower stress T1 response and larger standard deviations of 4.3 ± 2.8% in controls at 1.5 T . In CAD patients with remote myocardium, Liu et al. noted a blunted T1 response of 3.9 ± 0.6%, while Kuijpers et al. reported lower averages of 2.6 ± 3.4%. Similarly, another group of investigators reported that MOLLI 5(3)3 achieved a stress T1 response of 3.3% (1.5 T) and 4.4% (3 T) [47, 56]. Recently, stress T1 responses using regadenoson showed reactivity similar to those previously reported after adenosine administration .
It is encouraging that the stress T1 response can be elicited using more than one T1 mapping technique by independent groups of investigators and with different stress agents. At the same time, the fact that the ShMOLLI stress T1 response is larger by >40% than using MOLLI 5(3)3 based on the published numbers above deserves attention and discussion. Conventionally, CMR methods that compare images before and after an intervention (such as administration of a stress agent or GBCA, as in perfusion imaging and ECV mapping) within the same subject in a single scan session may improve inter-individual and inter-center consistencies of the imaging biomarker. However, the same cannot be said for stress T1 mapping based on current limited evidence. In the two studies cited above [28, 46], the resting T1 (955 ± 17 ms in Liu et al. and T1rest 977 ± 40 ms in Kuijpers et al.) amount to only a ~2% difference between these two techniques. In contrast, the inter-methodological differences in stress T1 responses differ by ~40% (approximately 6 vs. 4%, respectively)—i.e., a 20-fold worse agreement than for resting T1 values. Potential reasons for discrepancies in the stress T1 response between these two techniques may include factors such as selection of patients (with normal findings) as controls in the MOLLI study and control age differences, adenosine stress duration, adequacy, and maximal heart rate achieved; however, the technical differences between the ShMOLLI and MOLLI 5(3)3 T1 mapping techniques and their impact on the stress T1 response also require further consideration, as discussed below. Early standardization may be even more important for stress applications than for native resting T1.
The impact of heart rate variation on stress T1 mapping
SASHA T1 mapping is heart rate independent under optimal conditions, although there have been no reports of its application during dynamic stress thus far. It remains to be tested in practice by further comparisons whether the lower signal-to-noise ratio (SNR) known for this technique and whether imperfect saturation conditions may introduce confounds based on the known error dependencies (shown in Figs. 2, 3, 4 in the original paper ).
Factors other than heart rate that impact on stress T1 mapping
There are factors other than heart rate that may impact on the stress T1 response for a T1 mapping technique, which include T1 sensitivities to T2, magnetization transfer (MT) effects, and breath-hold duration and motion during stress conditions.
With regard to T2 sensitivities and MT effects, these properties that confer MOLLI-based techniques their recognized sensitivity to detecting disease  are likely to enhance their sensitivity to the stress T1 response elicited by ShMOLLI. Assuming that the underlying mechanism of the stress T1 response is mainly related to an increase in blood volume, the increased water content will directly affect MT and T2 to synergistically increase the measured T1. Further, the stress ShMOLLI-T1 response is likely to be enhanced by residual sensitivity to T2 elevations due to underlying BOLD (blood oxygenation level dependent) effects. The surplus BOLD response is characteristic of normal vascular reactivity [61, 62, 63] and will also accentuate the contrast to pathological changes. Conversely, while stress T1 mapping has not been reported using saturation-recovery techniques, the lack of MT and T2 dependencies will likely diminish the stress T1 response, especially given the higher variability (noise) typically seen in T1 estimation using saturation-recovery methods [6, 35, 64]. Recently improved inversion pulses in recent MOLLI variants target the accuracy of T1 by reducing T2 and MT sensitivities, which may be paradoxically detrimental to their sensitivity to detect stress T1 responses .
For the more recent MOLLI variants that use sampling schemes measured in seconds (rather than in heartbeats) , at increased heart rates, there will be more image acquisitions per inversion recovery experiment, and more energy deposited into bound proton pools. For example, MOLLI 5s(3s)3s would deploy as MOLLI 5(3)3 at a heart rate of 60 beats per minute, but at 120 beats per minute, MOLLI 10(6)6 would be deployed, with twice as many readouts. Thus, MT sensitivity between the actual variants deployed at rest and during stress is likely to differ significantly. What happens exactly is largely academic, as its clinical application is likely to be more impacted by the breath-hold requirements. Human subjects undergoing dynamic stress using the 5s(3s)3s sampling scheme would need to hold their breath typically for 12–14 s, longer than classic MOLLI under the same stress conditions. Kuijpers et al.  had reported substantial motion artefacts using MOLLI 5(3)3 for stress T1 mapping, and these are likely to worsen using MOLLI 5s(3s)3s due to longer breath-hold requirements. Recent studies agreed that motion remains a substantial concern for MOLLI acquisitions for stress applications, which could not be overcome by inline MOCO [47, 56].
It would be difficult to explain the observed dependencies quantitatively by simple partial-volume relaxivity summation. We draw attention to the complex spectrum of blood T1, T2, and volumetric reactivity between various vascular compartments in the brain (details in Figs. 11–14 in , supplemental material). Briefly, these demonstrate very significant differences in baseline values and stress reactivity of T1 and T2 of blood in various vascular compartments in the brain, with a disparately small blood volume attributed to the vaso-reactive arterial component when compared to the capillary and venous bed. These effects in the brain have been studied in response to CO2 administration, but not with adenosine or the dynamically changing tissue stress that occurs with each heart beat. These factors are important, as the dynamics of compartmental volume redistribution depend on time scales and the types of stimuli in the brain . Given the challenges to gather similar data for the heart, ultimately, the diagnostic performance of a method to study the heart during stress conditions will boil down to clinical evidence and independent head-to-head comparisons in clinical practice . Computer simulations and phantom experiments, while helpful as initial guides to assess a new method, may not fully replicate or account for factors encountered in the in vivo environment , especially in a complex and dynamic organ like the human heart.
Future directions and implications
Stress and rest T1 mapping is a novel technique with potential to assess ischaemia, coronary vasodilatory reserve, and the health of the micro-coronary circulation, without the need for GCBA. T1 mapping is a nascent field, and the exact biological mechanisms of native and stress T1 signals in various conditions have not been fully elucidated. The effects of other modalities of stress, including exercise and pharmacological agents, as well as other modulators of vascular reactivity on T1 may be explored to fully determine its clinical applicability. Stress T1 mapping is an active area of scientific development, including validation against quantitative perfusion measures, invasive coronary measurements and diagnostic performance in a variety of cardiac conditions [55, 66, 67, 68, 69, 70]. Over time, collective evidence will allow better understanding of the mechanisms for the observed changes for this emerging technique and its clinical utility in a wider patient population, including those with contraindications to GBCA.
The authors acknowledge support from the British Heart Foundation Centre of Research Excellence (Oxford, UK). The authors are supported by the NIHR Biomedical Research Centre, Oxford.
Compliance with ethical standards
Conflict of interest
Professor Stefan K. Piechnik has patent authorship rights for US patent 9285446 B2. Systems and methods for shortened Look-Locker inversion recovery (Sh-MOLLI) cardiac gated mapping of T1. Granted March 15, 2016. The patent is managed by Oxford University. All rights transferred exclusively to Siemens Medical. To date, SKP received £4396.92 for this IP, before tax and National Insurance deductions.
- 1.Moon J, Messroghli D, Kellman P, Piechnik S, Robson M, Ugander M, Gatehouse P, Arai A, Friedrich M, Neubauer S, Schulz-Menger J, Schelbert E (2013) Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 15(1):92CrossRefPubMedPubMedCentralGoogle Scholar
- 3.Piechnik SK, Ferreira VM, Dall’Armellina E, Cochlin LE, Greiser A, Neubauer S, Robson MD (2010) Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson 12:69CrossRefPubMedPubMedCentralGoogle Scholar
- 7.Weingärtner S, Akçakaya M, Basha T, Kissinger KV, Goddu B, Berg S, Manning WJ, Nezafat R (2014) Combined saturation/inversion recovery sequences for improved evaluation of scar and diffuse fibrosis in patients with arrhythmia or heart rate variability. Magn Reson Med 71(3):1024–1034CrossRefPubMedGoogle Scholar
- 9.Piechnik SK, Ferreira VM, Lewandowski AJ, Ntusi NAB, Banerjee R, Holloway C, Hofman MBM, Sado DM, Maestrini V, White SK, Lazdam M, Karamitsos T, Moon JC, Neubauer S, Leeson P, Robson MD (2013) Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI. J Cardiovasc Magn Reson 15:13CrossRefPubMedPubMedCentralGoogle Scholar
- 10.Dall’Armellina E, Piechnik SK, Ferreira VM, Si QL, Robson MD, Francis JM, Cuculi F, Kharbanda RK, Banning AP, Choudhury RP, Karamitsos TD, Neubauer S (2012) Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction. J Cardiovasc Magn Reson 14:15CrossRefPubMedPubMedCentralGoogle Scholar
- 11.Ferreira V, Piechnik S, Dall’Armellina E, Karamitsos T, Francis J, Choudhury R, Friedrich M, Robson M, Neubauer S (2012) Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson 14(1):42CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Ferreira VM, Piechnik SK, Dall’armellina E, Karamitsos TD, Francis JM, Ntusi N, Holloway C, Choudhury RP, Kardos A, Robson MD, Friedrich MG, Neubauer S (2013) T1 mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc Imaging 6(10):1048–1058CrossRefPubMedGoogle Scholar
- 13.Ferreira V, Piechnik S, Dall’Armellina E, Karamitsos T, Francis J, Ntusi N, Holloway C, Choudhury R, Kardos A, Robson M, Friedrich M, Neubauer S (2014) Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents. J Cardiovasc Magn Reson 16(1):36CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Dass S, Suttie JJ, Piechnik SK, Ferreira VM, Holloway CJ, Banerjee R, Mahmod M, Cochlin L, Karamitsos TD, Robson MD, Watkins H, Neubauer S (2012) Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy. Circ Cardiovasc Imaging 5(6):726–733CrossRefPubMedGoogle Scholar
- 17.Karamitsos TD, Piechnik SK, Banypersad S, Fontana M, Ntusi N, Ferreira VM, Whelan C, Myerson SG, Robson MD, Hawkins P, Neubauer S (2012) Non-contrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging. doi: 10.1016/j.jcmg.2012.11.013 (Published online before print) Google Scholar
- 18.Ntusi N, Piechnik S, Francis J, Ferreira V, Rai A, Matthews P, Robson M, Moon J, Wordsworth P, Neubauer S, Karamitsos T (2014) Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis—a clinical study using myocardial T1-mapping and extracellular volume quantification. J Cardiovasc Magn Reson 16(1):21CrossRefPubMedPubMedCentralGoogle Scholar
- 20.Ntusi N, O’Dwyer E, Dorrell L, Wainwright E, Piechnik S, Clutton G, Hancock G, Ferreira V, Cox P, Badri M, Karamitsos T, Emmanuel S, Clarke K, Neubauer S, Holloway C (2016) HIV-1-related cardiovascular disease is associated with chronic inflammation, frequent pericardial effusions, and probable myocardial edema. Circ Cardiovasc Imaging 9(3):e004430CrossRefPubMedGoogle Scholar
- 21.Ferreira VM, Marcelino M, Piechnik SK, Marini C, Karamitsos TD, Ntusi NA, Francis JM, Robson MD, Arnold JR, Mihai R, Thomas JD, Herincs M, Hassan-Smith ZK, Greiser A, Arlt W, Korbonits M, Karavitaki N, Grossman AB, Wass JA, Neubauer S (2016) Pheochromocytoma is characterized by catecholamine-mediated myocarditis, focal and diffuse myocardial fibrosis, and myocardial dysfunction. J Am Coll Cardiol 67(20):2364–2374CrossRefPubMedGoogle Scholar
- 22.Fontana M, White S, Banypersad S, Sado D, Maestrini V, Flett A, Piechnik S, Neubauer S, Roberts N, Moon J (2012) Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR. J Cardiovasc Magn Reson 14(1):88CrossRefPubMedPubMedCentralGoogle Scholar
- 23.Fontana M, Banypersad SM, Treibel TA, Maestrini V, Sado DM, White SK, Pica S, Castelletti S, Piechnik SK, Robson MD, Gilbertson JA, Rowczenio D, Hutt DF, Lachmann HJ, Wechalekar AD, Whelan CJ, Gillmore JD, Hawkins PN, Moon JC (2014) Native T1 mapping in transthyretin amyloidosis. JACC Cardiovasc Imaging 7(2):157–165CrossRefPubMedGoogle Scholar
- 25.Sado DM, White SK, Piechnik SK, Banypersad SM, Treibel T, Captur G, Fontana M, Maestrini V, Flett AS, Robson MD, Lachmann RH, Murphy E, Mehta A, Hughes D, Neubauer S, Elliott PM, Moon JC (2013) Identification and assessment of anderson-fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping. Circ Cardiovasc Imaging 6(3):392–398CrossRefPubMedGoogle Scholar
- 26.Sado DM, Maestrini V, Piechnik SK, Banypersad SM, White SK, Flett AS, Robson MD, Neubauer S, Ariti C, Arai A, Kellman P, Yamamura J, Schoennagel BP, Shah F, Davis B, Trompeter S, Walker M, Porter J, Moon JC (2015) Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload. J Magn Reson Imaging 41(6):1505–1511CrossRefPubMedGoogle Scholar
- 27.Mahmod M, Piechnik SK, Levelt E, Ferreira VM, Francis JM, Lewis A, Pal N, Dass S, Ashrafian H, Neubauer S, Karamitsos TD (2014) Adenosine stress native T1 mapping in severe aortic stenosis: evidence for a role of the intravascular compartment on myocardial T1 values. J Cardiovasc Magn Reson 16(1):1–8CrossRefGoogle Scholar
- 28.Liu A, Wijesurendra RS, Francis JM, Robson MD, Neubauer S, Piechnik SK, Ferreira VM (2016) Adenosine stress and rest T1 mapping can differentiate between ischemic, infarcted, remote, and normal myocardium without the need for gadolinium contrast agents. JACC Cardiovasc Imaging 9(1):27–36CrossRefPubMedPubMedCentralGoogle Scholar
- 29.Liu A, Wijesurendra RS, Ariga R, Mahmod M, Levelt E, Greiser A, Petrou M, Krasopoulos G, Forfar JC, Kharbanda RK, Channon KM, Neubauer S, Piechnik SK, Ferreira VM (2017) Splenic T1-mapping: a novel quantitative method for assessing adenosine stress adequacy for cardiovascular magnetic resonance. J Cardiovasc Magn Reson 19(1):1CrossRefPubMedPubMedCentralGoogle Scholar
- 32.Ferreira VM, Piechnik SK, Dall’Armellina E, Karamitsos TD, Francis JM, Ntusi N, Holloway C, Choudhury RP, Kardos A, Robson MD, Friedrich MG, Neubauer S (2013) T1 mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc Imaging 6(10):1048–1058CrossRefPubMedGoogle Scholar
- 37.Sado DM, White SK, Piechnik SK, Banypersad SM, Treibel T, Captur G, Fontana M, Maestrini V, Flett AS, Robson MD, Lachmann RH, Murphy E, Mehta A, Hughes D, Neubauer S, Elliott PM, Moon JC (2013) Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping. Circ Cardiovasc Imaging 6(3):392–398CrossRefPubMedGoogle Scholar
- 39.Piechnik SK, Ferreira VM, Lewandowski AJ, Ntusi NA, Banerjee R, Holloway C, Hofman MB, Sado DM, Maestrini V, White SK, Lazdam M, Karamitsos T, Moon JC, Neubauer S, Leeson P, Robson MD (2013) Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI. J Cardiovasc Magn Reson 15:13CrossRefPubMedPubMedCentralGoogle Scholar
- 40.Dabir D, Child N, Kalra A, Rogers T, Gebker R, Jabbour A, Plein S, Yu C-Y, Otton J, Kidambi A, McDiarmid A, Broadbent D, Higgins DM, Schnackenburg B, Foote L, Cummins C, Nagel E, Puntmann VO (2014) Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 16(1):1–12CrossRefGoogle Scholar
- 48.Levelt E, Piechnik SK, Mahmod M, Ferreira VM, Ariga R, Francis JM, Liu A, Sellwood J, Wijesurendra RS, Robson MD, Clarke K, Neubauer S, Karamitsos TD (2015) Adenosine stress native T1 mapping detects microvascular disease in diabetic cardiomyopathy, without the need for gadolinium-based contrast. J Cardiovasc Magn Reson 17(Suppl 1):Q55CrossRefPubMedCentralGoogle Scholar
- 49.Nayak K, Do HP, Yoon AJ, Fong M, Grazette L, Farhood S, Barr ML (2017) Vasodilator response in heart transplant recipients using T1-based myocardial blood volume mapping. In: Proceedings from the 20th annual SCMR scientific sessions, p 669Google Scholar
- 55.Puntmann VO, Peker E, Chandrashekhar Y, Nagel E (2016) T1 mapping in characterizing myocardial disease. Compr Rev 119(2):277–299Google Scholar
- 56.Puntmann VO, Peker E, Winau L, Heinke R, Schnoes K, Wichmann JL, Vogl T, Zeiher AM, Greiser A, Nagel E (2017) T1 mapping at rest and adenosine stress—comparison of T1 mapping sequences for feasibility and effect size. In: Proceedings from the 20th SCMR anual scientific sessions, p 241Google Scholar
- 57.van Dijk R, Kuijpers D, Kaandorp TAM, van Dijkman PRM, Vliegenthart R, van der Harst P, Oudkerk M (2017) Effects of caffeine intake prior to stress cardiac magnetic resonance perfusion imaging on regadenoson- versus adenosine-induced hyperemia as measured by T1 mapping. Int J Cardiovasc Imaging. doi: 10.1007/s10554-017-1157-4 PubMedCentralGoogle Scholar
- 67.Kramer CM, Chandrashekhar Y, Narula J (2016) The tissue issue. T1 mapping and the myocardium. JACC Cardiovasc Imaging 9 (1):88–90Google Scholar
- 69.Paiman EHM, Lamb HJ When should we use contrast material in cardiac MRI? J Magn Reson Imaging. doi: 10.1002/jmri.25754
- 70.Dastidar AG, Bucciarelli-Ducci C (2016) Coronary artery disease imaging: What is the role of magnetic resonance imaging? Dialogues Cardiovasc Med 21:267–276Google Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.